title: ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
abstract: The American College of Cardiology Foundation along with key specialty and subspecialty societies, conducted an appropriate use review of common clinical presentations for stable ischemic heart disease (SIHD) to consider use of stress testing and anatomic diagnostic procedures. This document reflects an updating of the prior Appropriate Use Criteria (AUC) published for radionuclide imaging (RNI), stress echocardiography (Echo), calcium scoring, coronary computed tomography angiography (CCTA), stress cardiac magnetic resonance (CMR), and invasive coronary angiography for SIHD. This is in keeping with the commitment to revise and refine the AUC on a frequent basis. A major innovation in this document is the rating of tests side by side for the same indication. The side-by-side rating removes any concerns about differences in indication or interpretation stemming from prior use of separate documents for each test. However, the ratings were explicitly not competitive rankings due to the limited availability of comparative evidence, patient variability, and range of capabilities available in any given local setting. The indications for this review are limited to the detection and risk assessment of SIHD and were drawn from common applications or anticipated uses, as well as from current clinical practice guidelines. Eighty clinical scenarios were developed by a writing committee and scored by a separate rating panel on a scale of 1 to 9, to designate Appropriate, May Be Appropriate, or Rarely Appropriate use following a modified Delphi process following the recently updated AUC development methodology. The use of some modalities of testing in the initial evaluation of patients with symptoms representing ischemic equivalents, newly diagnosed heart failure, arrhythmias, and syncope was generally found to be Appropriate or May Be Appropriate, except in cases where low pre-test probability or low risk limited the benefit of most testing except exercise electrocardiogram (ECG). Testing for the evaluation of new or worsening symptoms following a prior test or procedure was found to be Appropriate. In addition, testing was found to be Appropriate or May Be Appropriate for patients within 90 days of an abnormal or uncertain prior result. Pre-operative testing was rated Appropriate or May Be Appropriate only for patients who had poor functional capacity and were undergoing vascular or intermediate risk surgery with 1 or more clinical risk factors or an organ transplant. The exercise ECG was suggested as an Appropriate test for cardiac rehabilitation clearance or for exercise prescription purposes. Testing in asymptomatic patients was generally found to be Rarely Appropriate, except for calcium scoring and exercise testing in intermediate and high-risk individuals and either stress or anatomic imaging in higher-risk individuals, which were all rated as May Be Appropriate. All modalities of follow-up testing after a prior test or percutaneous coronary intervention (PCI) within 2 years and within 5 years after coronary artery bypass graft (CABG) in the absence of new symptoms were rated Rarely Appropriate. Pre-operative testing for patients with good functional capacity, prior normal testing within 1 year, or prior to low-risk surgery also were found to be Rarely Appropriate. Imaging for an exercise prescription or prior to the initiation of cardiac rehabilitation was Rarely Appropriate except for cardiac rehabilitation clearance for heart failure patients.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Wolk
authors.forename: Steven R
authors.initials: SR
authors.lastname: Bailey
authors.forename: John U
authors.initials: JU
authors.lastname: Doherty
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Douglas
authors.forename: Robert C
authors.initials: RC
authors.lastname: Hendel
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Kramer
authors.forename: James K
authors.initials: JK
authors.lastname: Min
authors.forename: Manesh R
authors.initials: MR
authors.lastname: Patel
authors.forename: Lisa
authors.initials: L
authors.lastname: Rosenbaum
authors.forename: Leslee J
authors.initials: LJ
authors.lastname: Shaw
authors.forename: Raymond F
authors.initials: RF
authors.lastname: Stainback
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Allen
mesh_terms: D000465:Algorithms; D002309:Cardiology / Q000592:standards*; D003324:Coronary Artery Disease / Q000175:diagnosis; D054059:Coronary Occlusion / Q000175:diagnosis; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003952:Diagnostic Imaging / Q000592:standards*; D004562:Electrocardiography; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis*; D061214:Patient Safety; D011829:Radiation Dosage; D018570:Risk Assessment / Q000592:standards*; D012307:Risk Factors; D014481:United States; D061205:Vascular Calcification / Q000175:diagnosis
keywords: ACCF Appropriate Use Criteria; SIHD; appropriateness criteria; imaging; ischemic heart disease; multimodality